Robert C.A.M. van Waardenburg

Author

University of Alabama at Birmingham ORCID

Also Known As

Eddy S. Yang, James E. Bradner, K J Yoon, Karina J. Yoon, R C van Waardenburg, R. C. A. M. van Waardenburg, R.C.A.M van Waardenburg, Robert C. A. M. Waardenburg, Robert C. A. M. van Waardenburg, Robert C.A.M Waardenburg

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham St. Jude Children's Research Hospital The Netherlands Cancer Institute Utrecht University Slotervaartziekenhuis

About

Robert C.A.M. van Waardenburg is an author at University of Alabama at Birmingham specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	750
2	Natural Sciences	7	7	360
3	Cell Biology	6	6	469
4	Biochemistry	4	4	190
5	Immunology	1	1	37

Robert C.A.M. van Waardenburg

Publications

970

Citations

H-Index

Page 1

	Year	Citations
Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Marc Maliepaard, Margôt A. van Gastelen, Akiko Tohgo, PubMed Breast OncologyChemoprevention StrategyBcrp-mediated ResistanceTumor BiologyOvarian Cancer	2001	234
Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines Dick Pluim, Robert C.A.M. van Waardenburg, Jos H. Beijnen, Cancer Chemotherapy and Pharmacology Oncogenic AgentMedicineTumor TargetingAnti-cancer AgentPharmacology	2004	96
DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin Mirjam Crul, Robert C.A.M. van Waardenburg, Suzanne Bocxe, Biochemical Pharmacology ChromatinGenome InstabilityCell DivisionGemcitabine CytotoxicityNatural Sciences	2002	92
Structure of a SUMO-binding-motif Mimic Bound to Smt3p–Ubc9p: Conservation of a Non-covalent Ubiquitin-like Protein–E2 Complex as a Platform for Selective Interactions within a SUMO Pathway David M. Duda, Robert C.A.M. van Waardenburg, Laura A. Borg, Journal of Molecular Biology Selective InteractionsProtein FunctionBiochemistryNatural SciencesSumo-binding-motif Mimic Bound	2007	64
32P-Postlabeling Assay for the Quantification of the Major Platinum-DNA Adducts Dick Pluim, Marc Maliepaard, Robert C.A.M. van Waardenburg, Analytical Biochemistry ChromatinBiochemistryNatural SciencesBioanalysisMass Spectrometry	1999	53
Defects in SUMO (Small Ubiquitin-related Modifier) Conjugation and Deconjugation Alter Cell Sensitivity to DNA Topoisomerase I-induced DNA Damage Hervé R. Jacquiau, Robert C.A.M. van Waardenburg, Robert J. D. Reid, Journal of Biological Chemistry Dna DamageSumo ModificationGeneticsSmall Ubiquitin-related ModifierMolecular Biology	2005	51
Platinated DNA Adducts Enhance Poisoning of DNA Topoisomerase I by Camptothecin Robert C.A.M. van Waardenburg, Laurina A. de Jong, Maria A.J. van Eijndhoven, Journal of Biological Chemistry	2004	47
Mutation of a Conserved Active Site Residue Converts Tyrosyl-DNA Phosphodiesterase I into a DNA Topoisomerase I-dependent Poison Xiaoping He, Robert C.A.M. van Waardenburg, Kerim Babaoglu, Journal of Molecular Biology ChromatinBiochemistryNatural SciencesOligonucleotideDna Replication	2007	44
Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line Robert C.A.M. van Waardenburg, Coby Meijer, Herman Burger, International Journal of Cancer C-myc Over-expressionC-myc Gene AmplificationTumor MicroenvironmentOncogenic AgentMedicine	1997	37
Analysis of the Active-Site Mechanism of Tyrosyl-DNA Phosphodiesterase I: A Member of the Phospholipase D Superfamily Stefan Gajewski, Evan Q. Comeaux, Nauzanene Jafari, Journal of Molecular Biology Proteinlipid InteractionSignal TransductionTyrosyl-dna PhosphodiesteraseBiochemistryNatural Sciences	2011	29

Page 1